BCL2L1 and leukemia: However, the treatment only marginally affected Bcl-2 and Bcl-xL levels in the leukemia cells, and even upregulated the anti-apoptotic protein Mcl-1 especially in Ba/F3-ITD mutant and Ba/F3-FLT3-WT cell lines (Fig. 2C).